Attention-deficit hyperactivity disorder (ADHD), like other psychiatric disorders, represents an evolving construct that has been refined and developed over the past several decades in response to research into its clinical nature and structure. The clinical presentation and course of the disorder have been extensively characterised. Efficacious medication-based treatments are available and widely used, often alongside complementary psychosocial approaches. However, their effectiveness has been questioned because they might not address the broader clinical needs of many individuals with ADHD, especially over the longer term. Non-pharmacological approaches to treatment have proven less effective than previously thought, whereas scientific and clinical studies are starting to fundamentally challenge current conceptions of the causes of ADHD in ways that might have the potential to alter clinical approaches in the future. In view of this, we first provide an account of the diagnosis, epidemiology, and treatment of ADHD from the perspective of both the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders and the eleventh edition of the International Classification of Diseases. Second, we review the progress in our understanding of the causes and pathophysiology of ADHD on the basis of science over the past decade or so. Finally, using these discoveries, we explore some of the key challenges to both the current models and the treatment of ADHD, and the ways in which these findings can promote new perspectives.
Copyright © 2020 Elsevier Ltd. All rights reserved.
[No authors listed] [No authors listed] NIH Consens Statement. 1998 Nov 16-18;16(2):1-37. NIH Consens Statement. 1998. PMID: 10868163 Review.
Modesto-Lowe V, Meyer A, Soovajian V. Modesto-Lowe V, et al. Conn Med. 2012 Oct;76(9):517-23. Conn Med. 2012. PMID: 23155670 Review.
Foy JM, Earls MF. Foy JM, et al. Pediatrics. 2005 Jan;115(1):e97-104. doi: 10.1542/peds.2004-0953. Pediatrics. 2005. PMID: 15629972
Ricketts EJ, Sturm A, McMakin DL, McGuire JF, Tan PZ, Smalberg FB, McCracken JT, Colwell CS, Piacentini J. Ricketts EJ, et al. J Child Adolesc Psychopharmacol. 2018 Dec;28(10):690-698. doi: 10.1089/cap.2018.0038. Epub 2018 Nov 2. J Child Adolesc Psychopharmacol. 2018. PMID: 30388029 Free PMC article. Clinical Trial.
Wilens TE, Isenberg BM, Kaminski TA, Lyons RM, Quintero J. Wilens TE, et al. Curr Psychiatry Rep. 2018 Sep 17;20(11):100. doi: 10.1007/s11920-018-0968-x. Curr Psychiatry Rep. 2018. PMID: 30221318 Review.
Nowak J, Aronin J, Beg F, O'Malley N, Ferrick M, Quattrin T, Pavlesen S, Hadjiargyrou M, Komatsu DE, Thanos PK. Nowak J, et al. Biomedicines. 2024 Aug 21;12(8):1914. doi: 10.3390/biomedicines12081914. Biomedicines. 2024. PMID: 39200379 Free PMC article. Review.
González-Villén R, Fernández-López ML, Checa-Ros A, Tortosa-Pinto P, Aguado-Rivas R, Garre-Morata L, Acuña-Castroviejo D, Molina-Carballo A. González-Villén R, et al. Biomedicines. 2024 Aug 9;12(8):1818. doi: 10.3390/biomedicines12081818. Biomedicines. 2024. PMID: 39200282 Free PMC article.
Harald W, Nicole K, Michaela S, Carola H, Nina S, Youli S, Thomas F, Frank-Michael K, Ulrich P, Matthias T, Artur M. Harald W, et al. J Clin Med. 2024 Jul 25;13(15):4357. doi: 10.3390/jcm13154357. J Clin Med. 2024. PMID: 39124625 Free PMC article.
Laatsch J, Stein F, Maier S, Matthies S, Sobanski E, Alm B, Tebartz van Elst L, Krug A, Philipsen A. Laatsch J, et al. Eur Arch Psychiatry Clin Neurosci. 2024 Jul 29. doi: 10.1007/s00406-024-01872-2. Online ahead of print. Eur Arch Psychiatry Clin Neurosci. 2024. PMID: 39073447
Desai S, Sharath HV, Qureshi MI, Raghuveer R. Desai S, et al. Cureus. 2024 Jun 20;16(6):e62739. doi: 10.7759/cureus.62739. eCollection 2024 Jun. Cureus. 2024. PMID: 39036155 Free PMC article.